Google+ Facebook Twitter Twitter

News flow cytometer

Merck, a leading science and technology company, has now launched its new CellStream flow cytometry system.

New flow cytometer

The new product for the life science industry was launched at the 33rd Congress of the International Society for the Advancement of Cytometry, which took place on April 28 to May 2 in Prague.

Merck’s new CellStream benchtop flow cytometry system is a compact and customisable flow cytometer that uses a camera for detection.

Its unique optics system and design give researchers unparalleled sensitivity for analyzing cells and submicron particles, plus the flexibility of up to seven lasers.

The optical system is based on patented technology unique to the company’s Amnis flow cytometers.

Related Articles

Viral suppression helps to prevent AIDS-defining cancers

Early, sustained antiretroviral therapy that results in long-term viral suppression, helps to prevent AIDS-defining cancers and, to a lesser degree, non-AIDS-defining cancers, it is claimed.

Journal-based learning: iStock

April Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at:

Primary HPV cervical screening

Following meetings with the British Association for Cytopathology (BAC), Public Health England (PHE) and the IBMS, the following has been agreed.

British Journal of Biomedical Science Issue 2 2018: a synopsis

Issue 2 of our journal is now completed. By the time you read this, the hardcopy may already have landed on your doormats, and those of you who have been to the website will already have accessed and read some of the papers. Editor Andrew Blann outlines the content in the latest issue.